According to a new report Europe Contrast Media Market, published by KBV Research, the Europe Contrast Media Market would witness market growth of 3.13% CAGR during the forecast period (2019-2025).
The Germany market is one of the major regions in the Europe Cardiovascular disorders Market by Country in 2018growing at a CAGR of 1.9 % during the forecast period. The UK market would witness a CAGR of 1.6% during (2019 - 2025). Additionally, The France market is witnessing a growth rate of 3.9% during (2019 - 2025).
The Iodinated market dominated the Russia Contrast Media Market by Product Type in 2018, thereby, achieving a market value of $188.6 million by 2025. The Gadolinium-based market is expected to witness a CAGR of 3.2% during (2019 - 2025).
The X-ray/CT market dominated the Italy Contrast Media Market by Modality in 2018, growing at a CAGR of 2.8 % during the forecast period. The Ultrasound market is projected to grow at a CAGR of 3.7% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/europe-contrast-media-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer AG, General Electric (GE) Co. (GE Healthcare), The Guerbet Group, Lantheus Holdings, Inc., Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Magnus Health, LLC (Veracross LLC), Imax Diagnostic Imaging Limited, and Daiichi Sankyo Company, Limited.
By Product Type
By Application
By Modality
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
